Episode 670: Cholesterol-reducer evolocumab associated with a nonsignificant increase in cardiovascular mortality (FOURIER)

POEM of the Week Podcast - A podcast by Mark Ebell and Michael Wilkes

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Categories:

Science & Medicine

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' Cholesterol-reducer evolocumab associated with a nonsignificant increase in cardiovascular mortality (FOURIER) '

Visit the podcast's native language site